Home /
Chemotherapy – Sir Charles Gairdner Hospital – Treatment Details
|
|
| Description: |
| Patients: This Phase II study involved 53 patients with malignant pleural mesothelioma; 45 men and 8 women. The median age was 63 years.
Treatment: The treatment consisted of two chemotherapy drugs; cisplatin (platinol) and gemcitabine (gemzar). Toxicity: Grade 3-4 toxicities included hematologic, diarrhea, infection, neurotoxicity, vomiting, and nausea. Results: Median survival was 11.2 months. Support: The study was supported in part by Eli Lilly. This company markets gemzar. Correspondence: M.J. Byrne, MD |
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."